Learn Latest About Skin Cancer on CME Webcast

OSU Wexner Medical Center logo Learn Lastest About Skin Cancer on CME Webcast. Doctor Mohs’ technique has spread to being used in a variety of body sites and cases. And what was once an informal training of the surgical technique from Dr Mohs’ Chemosurgery Clinic itself, is now taught broadly with exposure to Mohs surgery in every Dermatology residency.

This CME webcast is on Skin Cancer, and we’re delighted to bring on the program one of Ohio State University & James Cancer Hospital’s Dermatology and Mohs Surgery experts to share what is Mohs micrographic surgery and how it is used to treat skin cancer. We are pleased to introduce Associate Professor of Dermatology Dr Llana Pootrakul.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

Review the primary goal and key features of Mohs Micrographic Surgery, and which cutaneous tumors are appropriate.
Discuss comprehensive histologic margin evaluation of melanoma in situ.

You’ll also learn about the following:

  • Mohs Training
  • Pathology
  • Setting
  • Anesthesia
  • Timing

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches About Managing Complications of Chemotherapy

OSU Wexner Medical Center logo CME Webcast Teaches About Managing Complications of Chemotherapy. With more and more patients being exposed to cancer treatments, it is important for us to be familiar with the side effects and toxicities of modern chemotherapy agents. May is National Cancer Research Month. For today’s topic, We’ve invited one of Ohio State University James cancer hospitals Oncology experts. On this webcast, we get to welcome Associate Professor of Oncology Dr Edmund Folefac, who specializes in treating genitourinary cancers. In addition he is widely published cancer researcher.

What you’ll learn in this webcast

  • As a result of this educational activity, webcast participants will be able to:
  • Become familiar with common adverse reactions of newer chemotherapy agents including tyrosine kinase inhibitors, immunotherapy, and antibody drug conjugates.

Understand the basic principles of treating mild, moderate and severe toxicities to chemotherapy.

You’ll also learn about the following:

  • Evolution of Cancer Therapies
  • Red Flags
  • General Wellness
  • Long Term Therapy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn Latest About Alcohol Use Disorder

OSU Wexner Medical Center logo Learn Latest About Alcohol Use Disorder. Alcoholic beverages have been and still are important in many social, religious, and ceremonial uses. A toast for example is a common part of weddings. But alcohol, we now know has numerous negative effects. Alcohol can damage the heart, the liver, and is linked to numerous cancers. It can be consumed to excess and can lead to dependency and life-threatening withdrawal. So, how do we as physicians balance the common and important societal uses of alcohol with the negative health impacts and guide our patients to avoid and treat unhealthy alcohol use?

For this topic, we’ve invited a national leader of Alcohol Use Screening and intervention who happens to be here at Ohio State University Wexner Medical Center. We are pleased to introduce Professor of Internal Medicine Dr Daniel Jonas. Dan is the division director of General Internal Medicine here at Ohio State.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

1. Describe unhealthy alcohol use
2. Understand the burden of unhealthy alcohol use
3. Review an evidence-based, practical approach for
4. Incorporate cases that cover common clinical scenarios

You’ll also learn about the following:

  • Motivational Interviewing
  • Screening
  • Follow-up
  • Moderate Use
  • Pharmacotherapy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Emotional Support Animals on Webcast

OSU Wexner Medical Center logo Learn About Emotional Support Animals on Webcast. So what exactly constitutes an Emotional Support Animal? What are the considerations for us as medical professions in evaluating patients for an ESA? To elaborate on this topic, We’ve invited a Psychiatry expert from the Ohio State University Wexner Medical Center. Dr Meera Menon is an Assistant Professor of Psychiatry and Behavioral Health.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Describe relevant federal and state laws
  • Explore the evidence base for the use of ESA
  • Review the process of conducting an ESA evaluation and pertinent ethical considerations
  • Consider liability concerns and strategies to reduce liability

You’ll also learn about the following:

  • Who Can Evaluate?
  • Disability
  • Who Recommends?
  • Diagnosis
  • Social Determinants

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Physicians Teach Learners About Buprenorphine Treatment

OSU Wexner Medical Center logo Physicians Teach Learners About Buprenorphine Treatment. Joining us in the studio today to discuss buprenorphine is Dr. Erin McKnight. She is an Associate Professor of Pediatrics at the Ohio State University and is the medical director of the Substance Use Treatment and Recovery Program at Nationwide Children’s Hospital. And we also have Dr. Lucas McKnight who is a hospitalist, an Assistant Professor of Internal Medicine and Pediatrics, and also the Associate Program Director of the Internal Medicine Pediatrics Residency Program here at OSU.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Learn outpatient strategies for buprenorphine initiation to avoid precipitated withdrawal
  • Understand stabilization and outpatient long-term management
  • Acknowledge need for inpatient initiation of buprenorphine
  • Understand low dose buprenorphine initiation strategies

You’ll also learn about the following:

  • Opioid use disorder demographics
  • The role of the hospitalist in treating opioid use disorder
  • Outpatient scheduling strategies
  • When to suspect opioid use disorder
  • Pregnancy and opioid use disorder treatment
  • When to refer
  • Parental notification and opioid use disorder treatment
  • Discharge planning after initiating buprenorphine as an inpatient

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.